A Prospective Study of an HLA-Haploidentical Peripheral Blood Stem Cell Transplantation Regimen Based on Modification of the Dose of Posttransplant Cyclophosphamide for Poor Prognosis or Refractory Hematological Malignancies

The optimal dose of posttransplant cyclophosphamide (PTCy) for use in patients undergoing HLA-haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide (PTCy-haplo) has not been sufficiently examined. This study evaluates the safety and efficacy of HLA-haploidentical hem...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamae, Hirohisa, Okamura, Hiroshi, Hirose, Asao, Koh, Hideo, Nakashima, Yasuhiro, Nakamae, Mika, Nishimoto, Mitsutaka, Makuuchi, Yosuke, Kuno, Masatomo, Harada, Naonori, Takakuwa, Teruhito, Hino, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340897/
https://www.ncbi.nlm.nih.gov/pubmed/35906755
http://dx.doi.org/10.1177/09636897221112098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340897/
https://www.ncbi.nlm.nih.gov/pubmed/35906755
http://dx.doi.org/10.1177/09636897221112098

Ejemplares similares